Bayer HealthCare Announces the Launch of Aleve® PM: The First and Only OTC PM Pain Reliever with a Sleep Aid Plus the 12-Hour Pain Relieving Strength of Aleve

Bayer HealthCare Announces the Launch of Aleve® PM: The First and Only OTC PM Pain Reliever with a Sleep Aid Plus the 12-Hour Pain Relieving Strength of Aleve

WHIPPANY, N.J., Sept. 15, 2014 /PRNewswire/ -- Today, Bayer HealthCare LLC announces an exciting innovation in the nighttime pain reliever category with the launch of Aleve® PM, now available at retailers nationwide.  Aleve PM is the first over-the-counter (OTC) PM product with a safe sleep aid plus the 12-hour pain relieving strength of Aleve for pain relief that can last until the morning.

Aleve PM is a two pill dose.  Each caplet contains naproxen sodium (220 mg), which can provide up to 12-hours of pain relief, and diphenhydramine HCl (25 mg), which is a sleep aid.  The naproxen sodium (220 mg) in Aleve PM works by temporarily blocking the body's production of naturally occurring chemicals called prostaglandins.  Prostaglandins play a direct role in pain.

"The launch of Aleve PM is an important milestone for Bayer HealthCare and represents our commitment to developing new, safe and effective over-the-counter products that address unmet consumer needs," said Laura Schwieterman, Director of ALEVE. "Pain can not only delay the onset of sleep, it can cause frequent or early morning awakenings and prevent restful sleep.  With Aleve PM, consumers can now benefit from the 12 hour pain relieving strength of Aleve plus a good night's sleep for a better morning."

Aleve PM is now available at retailers nationwide. For more information about Aleve PM please visit www.AlevePM.com

Read Aleve PM Fact Sheet:  http://origin-qps.onstreammedia.com/origin/multivu_archive/ENR/FX-NY11333-091514-1.pdf

About Aleve PMAleve PM is the first and only over-the-counter (OTC) PM product with a safe sleep aid plus the 12-hour pain relieving strength of Aleve.  Aleve PM should be taken as directed by the product label.  Adults and children 12 years of age and over should take two caplets at bedtime. Do not take more than two caplets in 24 hours and do not take more than directed.  Drink a full glass of water with each dose.  If taken with food, the product may take longer to work.

About Bayer HealthCare The Bayer Group is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 18.9 billion (2013), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare's aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 56,000 employees (Dec 31, 2013) and is represented in more than 100 countries. More information is available at www.healthcare.bayer.com

The Consumer Care division of Bayer HealthCare is headquartered in Whippany, N.J. USA.  Bayer's Consumer Care division is among the largest marketers of over-the-counter medications and nutritional supplements in the world. Some of the most trusted and recognizable brands in the world today come from the Bayer portfolio of products. These include Aleve®, Alka-Seltzer®, Alka-Seltzer Plus®, Apronax®, Aspirin®, Bactine®, Bayer® Aspirin, Bepanthen®, Bepanthol®, Berocca®, Cal-D-Vita/Elevit®, Canesten®, Flanax®, Flintstones™ Vitamin, Midol®, One A Day® Vitamin, Phillips'® Milk of Magnesia, Redoxon®, Rennie®, Supradyn®, Talcid® and Vital 50 Plus®.

Forward-Looking Statements This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Follow us on Facebook: www.facebook.com/healthcare.bayer
Follow us on Twitter: https://twitter.com/BayerHealthCare

Photo - http://photos.prnewswire.com/prnh/20140912/145837
Logo - http://photos.prnewswire.com/prnh/20140312/NY79226LOGO 
PDF - http://origin-qps.onstreammedia.com/origin/multivu_archive/ENR/FX-NY11333-091514-1.pdf

SOURCE Bayer HealthCare, LLC
 

Suggested Articles

AMAG's female libido drug Vyleesi has just won FDA approval. But will it reach blockbuster state? Management and analysts have different opinions.

Roche’s Genentech new innovation targets cancer cells via video game to raise awareness of personalized medicine, tumor types and biomarker testing.

Alexion is undergoing a major makeover by moving away from ultra-rare diseases, but it still has more to pursue in an effort to back up Soliris.